Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Zevra Therapeutics is a biotech company focused on developing and commercializing therapies for rare diseases. Its portfolio includes approved products like AZSTARYS and OLPRUVA, and late-stage candidates such as MIPLYFFA for Niemann-Pick disease type C. The company leverages proprietary technology, strategic acquisitions, and collaborations to address unmet medical needs in niche markets worldwide. Its business model emphasizes innovation, targeted commercialization, and pipeline expansion in the rare disease space.
This description was generated via AI from an annual report. Updated about 1 year ago.